A detailed history of China Universal Asset Management Co., Ltd. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 27,225 shares of MRVI stock, worth $120,334. This represents 0.03% of its overall portfolio holdings.

Number of Shares
27,225
Previous 15,604 74.47%
Holding current value
$120,334
Previous $111,000 103.6%
% of portfolio
0.03%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$6.84 - $9.73 $79,487 - $113,072
11,621 Added 74.47%
27,225 $226,000
Q2 2024

Jul 19, 2024

SELL
$6.87 - $11.34 $67,532 - $111,472
-9,830 Reduced 38.65%
15,604 $111,000
Q1 2024

Apr 29, 2024

BUY
$5.11 - $8.76 $51,825 - $88,843
10,142 Added 66.32%
25,434 $221,000
Q4 2023

May 21, 2024

SELL
$4.7 - $9.87 $47,667 - $100,101
-10,142 Reduced 39.88%
15,292 $100,000
Q4 2023

Jan 23, 2024

BUY
$4.7 - $9.87 $55,934 - $117,462
11,901 Added 350.96%
15,292 $100,000
Q3 2023

May 21, 2024

BUY
$9.14 - $12.85 $15,190 - $21,356
1,662 Added 96.12%
3,391 $33,000
Q3 2023

Oct 30, 2023

BUY
$9.14 - $12.85 $15,190 - $21,356
1,662 Added 96.12%
3,391 $34,000
Q2 2023

May 21, 2024

SELL
$12.09 - $15.0 $689 - $855
-57 Reduced 3.19%
1,729 $21,000
Q2 2023

Jul 27, 2023

SELL
$12.09 - $15.0 $689 - $855
-57 Reduced 3.19%
1,729 $21,000
Q1 2023

May 21, 2024

BUY
$12.99 - $16.48 $5,845 - $7,416
450 Added 33.68%
1,786 $25,000
Q1 2023

Apr 27, 2023

BUY
$12.99 - $16.48 $5,845 - $7,416
450 Added 33.68%
1,786 $25,000
Q4 2022

May 21, 2024

SELL
$12.5 - $24.78 $301,225 - $597,148
-24,098 Reduced 94.75%
1,336 $19,000
Q4 2022

Jan 31, 2023

BUY
$12.5 - $24.78 $1,300 - $2,577
104 Added 8.44%
1,336 $19,000
Q3 2022

Oct 21, 2022

BUY
$20.6 - $30.37 $25,379 - $37,415
1,232 New
1,232 $31,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $581M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.